Добавил:
Upload Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Health Insurance act (без изменений).docx
Скачиваний:
2
Добавлен:
13.11.2019
Размер:
87.92 Кб
Скачать

§ 46. Assumption of obligations to pay for the sale of medicinal products

(1)        The health insurance fund is deemed to have assumed an obligation to pay for the sale of a medicinal product to the extent and under the conditions provided for in this Act if, within thirty calendar days after the receipt of the documents on which the assumption of the obligation is based through the prescription centre specified § 81 of the Medicinal Products Act the health insurance fund has not notified the retailer of the medicinal product of its refusal to assume the obligation.

(2)        The health insurance fund may refuse to assume an obligation to pay for the sale of a medicinal product if upon the sale of the medicinal product, the requirements for the sale of the medicinal product were violated.  

(20.12.07 entered into force 1.09.08 - RT I 2008, 3, 22)

4)         the circumstances under which assumption of an obligation is contingent upon prior written approval from the health insurance fund;

5)         the scope of the reporting obligation of the retailer of medicinal products and the obligation to submit information concerning insured persons to the health insurance fund, and the composition of the information to be submitted;

6)         other conditions necessary for ensuring the efficient and purposeful use of health insurance funds.

(3)        Assumption of an obligation to pay for the sale of a medicinal product may be refused if the sale of the medicinal product is not in conformity with the provisions of legislation or of a contract entered into with the health insurance fund.

 

§ 47. Supplementary benefit for medicinal products.

(1)        The health insurance fund shall additionally compensate for justified and certified amounts ranging from 6000 to 20 000 kroons which are paid during a calendar year for medicinal products which are entered in the list of medicinal products and are necessary for the out-patient treatment of an insured person (supplementary benefit for medicinal products).

(2)        The size of supplementary benefit for medicinal products shall be calculated by the health insurance fund on the basis of an application by an insured person or his or her legal representative according to the information in the health insurance database.

(3)        The amounts paid by the health insurance fund, the basic rate of cost-sharing and the amounts exceeding a reference price or a price established in a price agreement shall not be taken into account upon calculation of supplementary benefit for medicinal products.

(4)        If an amount calculated pursuant to subsection (3) of this section is 6000 to 10 000 kroons, the health insurance fund shall compensate 50 per cent of the share exceeding 6000 kroons.

(5)        If an amount calculated pursuant to subsection (3) of this section is 10 000 to 20 000 kroons, the health insurance fund shall, in addition to the amount calculated pursuant to subsection (4) of this section, compensate 75 per cent of the share exceeding 10 000 kroons.

(6)        The health insurance fund shall not additionally compensate for shares of amounts calculated pursuant to subsection (3) of this section which exceed 20 000 kroons.

(7)        The detailed procedure for application for and payment of supplementary benefits for medicinal products shall be established by a regulation of the Minister of Social Affairs.